The US pharma giant Johnson &Johnson has moved an application in India seeking permission to conduct clinical trials of its single-dose Covid-19 vaccine on children in...
The Union Health Ministry on Saturday announced that Johnson and Johnson’s single-dose Covid-19 vaccine Janssen has been approved for emergency use in India.
Amid the severe shortage of vaccines across the country, the Centre on Thursday said the availability of vaccines would rise manifold by August with supplies flowing...
Such pauses are an expected part of any clinical study, especially large studies which includes thousands of people, said Johnson& Johnson which is conducting highest profile...